scispace - formally typeset
Search or ask a question
Institution

University of Lorraine

EducationNancy, France
About: University of Lorraine is a education organization based out in Nancy, France. It is known for research contribution in the topics: Population & Context (language use). The organization has 11942 authors who have published 25010 publications receiving 425227 citations. The organization is also known as: Lorraine University.


Papers
More filters
Book ChapterDOI
01 Jan 2013
TL;DR: In this article, the authors discuss Poisson-Lie groups and their infinitesimal counterparts Lie bialgebras and show that there is a functor which associates to every Poisson -Lie group a Lie algebra and that every finite-dimensional Lie algebra is the Lie bilinear bialgebra of some Poisson group, which can be chosen to be connected and simply connected.
Abstract: In this chapter we discuss Poisson–Lie groups and their infinitesimal counterparts Lie bialgebras. A Poisson–Lie group is a Lie group G which is equipped with a Poisson structure π, having the property that the product map on G is a morphism of Poisson manifolds. A Lie bialgebra is a Lie algebra which is at the same time a Lie coalgebra, the algebra and coalgebra structures satisfying some compatibility relation. We show that there is a functor which associates to every Poisson–Lie group a Lie bialgebra and that every finite-dimensional Lie bialgebra is the Lie bialgebra of some Poisson–Lie group, which can be chosen to be connected and simply connected. Using dressing actions, we shortly discuss the symplectic leaves of Poisson–Lie groups.

84 citations

Journal ArticleDOI
TL;DR: A genome-wide association meta-analysis combining data from European-ancestry individuals and using a dense variant map from 1000 genomes imputation panel identified novel loci associated with circulating VEGF levels and explored biological links between genes in the associated loci using Ingenuity Pathway Analysis.
Abstract: Vascular endothelial growth factor (VEGF) is an angiogenic and neurotrophic factor, secreted by endothelial cells, known to impact various physiological and disease processes from cancer to cardiovascular disease and to be pharmacologically modifiable. We sought to identify novel loci associated with circulating VEGF levels through a genome-wide association meta-analysis combining data from European-ancestry individuals and using a dense variant map from 1000 genomes imputation panel. Six discovery cohorts including 13,312 samples were analyzed, followed by in-silico and de-novo replication studies including an additional 2,800 individuals. A total of 10 genome-wide significant variants were identified at 7 loci. Four were novel loci (5q14.3, 10q21.3, 16q24.2 and 18q22.3) and the leading variants at these loci were rs114694170 (MEF2C, P = 6.79x10-13), rs74506613 (JMJD1C, P = 1.17x10-19), rs4782371 (ZFPM1, P = 1.59x10-9) and rs2639990 (ZADH2, P = 1.72x10-8), respectively. We also identified two new independent variants (rs34528081, VEGFA, P = 1.52x10-18; rs7043199, VLDLR-AS1, P = 5.12x10-14) at the 3 previously identified loci and strengthened the evidence for the four previously identified SNPs (rs6921438, LOC100132354, P = 7.39x10-1467; rs1740073, C6orf223, P = 2.34x10-17; rs6993770, ZFPM2, P = 2.44x10-60; rs2375981, KCNV2, P = 1.48x10-100). These variants collectively explained up to 52% of the VEGF phenotypic variance. We explored biological links between genes in the associated loci using Ingenuity Pathway Analysis that emphasized their roles in embryonic development and function. Gene set enrichment analysis identified the ERK5 pathway as enriched in genes containing VEGF associated variants. eQTL analysis showed, in three of the identified regions, variants acting as both cis and trans eQTLs for multiple genes. Most of these genes, as well as some of those in the associated loci, were involved in platelet biogenesis and functionality, suggesting the importance of this process in regulation of VEGF levels. This work also provided new insights into the involvement of genes implicated in various angiogenesis related pathologies in determining circulating VEGF levels. The understanding of the molecular mechanisms by which the identified genes affect circulating VEGF levels could be important in the development of novel VEGF-related therapies for such diseases.

84 citations

Journal ArticleDOI
TL;DR: In this article, a segment-like antimony nanorod encapsulated in hollow carbon tube electrode material (Sb@HCT) was prepared, which exhibits excellent potassium storage properties: in the case of potassium bis(fluorosulfonyl)imide (KFSI) electrolyte, Sb@ HCT displays a reversible capacity of up to 453.4 mAh·g−1 at a current density of 0.5 A·g −1 and good rate performance.
Abstract: K-ion battery (KIB) is a new-type energy storage device that possesses potential advantages of low-cost and abundant resource of potassium. To develop advanced electrode materials for accommodating the large size and high activity of potassium ion is of great interests. Herein, a segment-like antimony (Sb) nanorod encapsulated in hollow carbon tube electrode material (Sb@HCT) was prepared. Beneficial from the virtue of abundant nitrogen doping in carbon tube, one-dimensional and hollow structure advantages, Sb@HCT exhibits excellent potassium storage properties: in the case of potassium bis(fluorosulfonyl)imide (KFSI) electrolyte, Sb@HCT displays a reversible capacity of up to 453.4 mAh·g−1 at a current density of 0.5 A·g−1 and good rate performance (a capacity of 211.5 mAh·g−1 could be achieved at an ultrahigh rate of 5 A·g−1). Additionally, Sb@HCT demonstrates excellent long-cycle stability at a current density of 2 A·g−1 over 120 cycles. Meanwhile, electrolyte optimization is an effective strategy for greatly improving electrochemical performance. Through ex-situ characterizations, we disclosed the potassiation of Sb anode is quite reversible and undergoes multistep processes, combining solid solution reaction and two-phase reaction.

84 citations

Journal ArticleDOI
TL;DR: In this paper, two different types of commercial tannins, namely chestnut (a hydrolysable tannin) and mimosa (a condensed flavonoid tantiol tantilin), were used with two different kinds of hardener, namely hexamine and glyoxal, to upgrade soy-based adhesives for bonding wood particleboard.
Abstract: Two different types of commercial tannins, namely chestnut (a hydrolysable tannin) and mimosa (a condensed flavonoid tannin), were used with two different types of hardener, namely hexamine and glyoxal, to upgrade soy-based adhesives for bonding of wood particleboard. Different soy-based adhesive formulations were tested by differential scanning calorimetry (DSC) and by thermomechanical analysis (TMA). The physical properties of different adhesive formulations such as viscosity, solid contents, acidity and density were also measured. One-layer laboratory particleboards bonded with the experimental adhesive formulations were prepared and tested. Based on the results obtained, tannins appear to decrease effectively soy-based adhesives’ viscosity. The TMA analysis showed that chestnut tannin extract appeared to react well with soy flour and to improve the soy flour adhesion properties. The TMA results also showed that both tannin types shorten the adhesives gel time and gel temperature. The DSC analysis also showed that tannin changes the thermal properties of soy-based adhesive and decreases both its glass transition temperature (Tg) and its denaturation temperature (Td). Moreover, particleboard bonded with tannin-modified adhesives showed internal bond strength results higher than particleboard bonded with unmodified soy adhesive. Thickness swelling and water absorption of the boards decreased when using tannins in soy-based adhesive formulations.

84 citations

Journal ArticleDOI
TL;DR: Patients who had an acute ischemic stroke admitted directly to a comprehensive stroke center (MS patients) with endovascular capacities may have better 90-day outcomes than those receiving DS treatment, suggesting a need for adequately powered studies.
Abstract: Background The effectiveness of mechanical thrombectomy (MT) in acute ischemic stroke due to large vessel occlusion is time-dependent. While only stroke centers with endovascular capabilities perform MT, many patients who had a stroke initially present to the closest primary stroke centers capable of administering earlier intravenous thrombolysis, and then require to be transferred to a comprehensive stroke center for MT. Purpose To compare the outcomes of this care pathway (drip and ship (DS)) with that whereby patients are directly transferred to a comprehensive stroke center (mothership (MS)). Methods We performed a systematic review and meta-analysis of published studies using several electronic databases to determine whether successful reperfusion (modified Thrombolysis In Cerebral Infarction ≥2b), functional independence at 90 days (modified Rankin Scale score ≤2), symptomatic intracranial hemorrhage, and 90-day mortality differed between those who underwent MT with the DS or the MS treatment pathway. Outcomes were meta-analyzed and the results expressed as adjusted relative risk (aRR) for the primary analysis and unadjusted relative risk (uRR) for secondary analysis. Results Eight studies including 2068 patients were selected, including one study reporting results fully adjusted for baseline characteristics. Patients undergoing MS had better functional independence than those undergoing DS (uRR=0.87, 95% CI 0.81 to 0.93; aRR=0.87, 95% CI 0.77 to 0.98). No difference was found between the treatment pathways in successful reperfusion (uRR=1.05, 95% CI 0.95 to 1.15; aRR=1.00, 95% CI 0.92 to 1.10), symptomatic intracranial hemorrhage (uRR=1.37, 95% CI 0.91 to 2.06; aRR, 1.53, 95% CI 0.79 to 2.98), and 90-day mortality (uRR=1.00, 95% CI 0.84 to 1.19; aRR=1.21, 95% CI 0.89 to 1.64). Conclusions Patients who had an acute ischemic stroke admitted directly to a comprehensive stroke center (MS patients) with endovascular capacities may have better 90-day outcomes than those receiving DS treatment. However, major limitations of current evidence (ie, retrospective studies and selection bias) suggest a need for adequately powered studies. Multicenter randomized controlled trials are expected to answer this question.

84 citations


Authors

Showing all 12161 results

NameH-indexPapersCitations
Jonathan I. Epstein138112180975
Peter Tugwell129948125480
David Brown105125746827
Faiez Zannad10383990737
Sabu Thomas102155451366
Francis Martin9873343991
João F. Mano9782236401
Jonathan A. Epstein9429927492
Muhammad Imran94305351728
Laurent Peyrin-Biroulet9090134120
Athanase Benetos8339131718
Michel Marre8244439052
Bruno Rossion8033721902
Lyn March7836762536
Alan J. M. Baker7623426080
Network Information
Related Institutions (5)
University of Paris
174.1K papers, 5M citations

95% related

École Normale Supérieure
99.4K papers, 3M citations

94% related

Centre national de la recherche scientifique
382.4K papers, 13.6M citations

94% related

École Polytechnique Fédérale de Lausanne
98.2K papers, 4.3M citations

94% related

National Research Council
76K papers, 2.4M citations

93% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202375
2022478
20213,153
20202,987
20192,799
20182,593